In a poster presented at ASBMR 2021, researchers compared fracture rates and treatment adherence in women with osteoporosis who received risedronate gastro-resistant vs oral immediate-release bisphosphonates.
Rates of biochemically verified prenatal cannabis use increased significantly among pregnant women in Northern California during the COVID-19 pandemic.
Menopausal hormone therapy is not associated with increased risks for cardiovascular disease or type 2 diabetes among middle-aged postmenopausal women.
Dermatoses of the skin, and their relevance to the early detection of many systemic forms of cancer, are reviewed.
Several metabolic disorders have been linked with an increased risk of contracting COVID-19. Researchers sought to discover whether women with polycystic ovary syndrome also fell into this higher-risk category.
The country’s leading health agency on Wednesday implored all Americans who are pregnant, breastfeeding, or planning to become pregnant to get a COVID-19 vaccine.
Polycystic ovary syndrome (PCOS) cost an estimated $8 billion to diagnose and treat nationwide in 2020.
EVOLVE was a large, multinational, prospective, noninterventional, multicenter study of pregnant women with preexisting type 1 or type 2 diabetes to evaluate the safety of detemir vs other basal insulins in pregnancy. Women in early pregnancy from 92 sites in 17 countries were enrolled.
A history of migraine is associated with higher severity of menopause symptoms.
For patients with persistent, recurrent, or metastatic cervical cancer who are receiving chemotherapy with or without bevacizumab, progression-free and overall survival is significantly longer with pembrolizumab versus placebo.
